A citation-based method for searching scientific literature

Jan Bühring, Michael Hecker, Brit Fitzner, Uwe Klaus Zettl. Aging Dis 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations.
Cristina Valencia-Sanchez, Brent P Goodman, Jonathan L Carter, Dean M Wingerchuk. Mult Scler 2019
8
50

Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies.
Oliver Findling, Larissa Hauer, Thomas Pezawas, Paulus S Rommer, Walter Struhal, Johann Sellner. J Clin Med 2020
19
50

Physical activity and multiple sclerosis: a meta-analysis.
Robert W Motl, Edward McAuley, Erin M Snook. Mult Scler 2005
320
50

Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.
Laxmi S Mehta, Theresa M Beckie, Holli A DeVon, Cindy L Grines, Harlan M Krumholz, Michelle N Johnson, Kathryn J Lindley, Viola Vaccarino, Tracy Y Wang, Karol E Watson,[...]. Circulation 2016
500
50

GRADE guidelines: 7. Rating the quality of evidence--inconsistency.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
50

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
50

Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study.
Rebecca Persson, Sally Lee, Marianne Ulcickas Yood, Michael Wagner, Neil Minton, Steve Niemcryk, Anders Lindholm, Amber Evans, Susan Jick. Mult Scler Relat Disord 2020
14
50

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.
Jelena-Rima Ghadri, Ilan Shor Wittstein, Abhiram Prasad, Scott Sharkey, Keigo Dote, Yoshihiro John Akashi, Victoria Lucia Cammann, Filippo Crea, Leonarda Galiuto, Walter Desmet,[...]. Eur Heart J 2018
451
50

Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.
Raffaele Palladino, Ruth Ann Marrie, Azeem Majeed, Jeremy Chataway. JAMA Neurol 2020
18
50

Traditional risk factors may not explain increased incidence of myocardial infarction in MS.
Ruth Ann Marrie, Allan Garland, Stephen Allan Schaffer, Randy Fransoo, Stella Leung, Marina Yogendran, Elaine Kingwell, Helen Tremlett. Neurology 2019
11
50

A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.
Rebecca L Morgan, Kristina A Thayer, Nancy Santesso, Alison C Holloway, Robyn Blain, Sorina E Eftim, Alexandra E Goldstone, Pam Ross, Mohammed Ansari, Elie A Akl,[...]. Environ Int 2019
57
50

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Ali Manouchehrinia, Radu Tanasescu, Christopher R Tench, Cris S Constantinescu. J Neurol Neurosurg Psychiatry 2016
60
50

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.
Ruth Ann Marrie, Nadia Reider, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Gary Cutter, Stephen Reingold, Per Soelberg Sorensen. Mult Scler 2015
85
50

Smoking and multiple sclerosis: an updated meta-analysis.
Adam E Handel, Alexander J Williamson, Giulio Disanto, Ruth Dobson, Gavin Giovannoni, Sreeram V Ramagopalan. PLoS One 2011
168
50

GRADE guidelines 6. Rating the quality of evidence--imprecision.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist,[...]. J Clin Epidemiol 2011
50

How to perform a meta-analysis with R: a practical tutorial.
Sara Balduzzi, Gerta Rücker, Guido Schwarzer. Evid Based Ment Health 2019
538
50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
50

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
Holger J Schünemann, Carlos Cuello, Elie A Akl, Reem A Mustafa, Jörg J Meerpohl, Kris Thayer, Rebecca L Morgan, Gerald Gartlehner, Regina Kunz, S Vittal Katikireddi,[...]. J Clin Epidemiol 2019
173
50

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment.
Jeffrey A Cohen, Maria Trojano, Ellen M Mowry, Bernard Mj Uitdehaag, Stephen C Reingold, Ruth Ann Marrie. Mult Scler 2020
19
50

Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
H Roshanisefat, S Bahmanyar, J Hillert, T Olsson, S Montgomery. Eur J Neurol 2014
43
50

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
50

Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.
Benjamin W Ewanchuk, Marjan Gharagozloo, Evelyn Peelen, Lara A Pilutti. Mult Scler Relat Disord 2018
8
50

Fingolimod and cardiac risk: latest findings and clinical implications.
Wendy S Vargas, Jai S Perumal. Ther Adv Drug Saf 2013
14
50

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
50

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
Gustavo Luna, Peter Alping, Joachim Burman, Katharina Fink, Anna Fogdell-Hahn, Martin Gunnarsson, Jan Hillert, Annette Langer-Gould, Jan Lycke, Petra Nilsson,[...]. JAMA Neurol 2020
158
50

The current role of mitoxantrone in the treatment of multiple sclerosis.
Eleonora Cocco, Maria Giovanna Marrosu. Expert Rev Neurother 2014
18
50

Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.
Rajalakshmi Santhanakrishnan, Na Wang, Martin G Larson, Jared W Magnani, David D McManus, Steven A Lubitz, Patrick T Ellinor, Susan Cheng, Ramachandran S Vasan, Douglas S Lee,[...]. Circulation 2016
292
50

High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Elham Jadidi, Mohammad Mohammadi, Tahereh Moradi. Mult Scler 2013
65
50

Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.
Ruth Geraldes, Margaret M Esiri, Rafael Perera, Sydney A Yee, Damian Jenkins, Jacqueline Palace, Gabriele C DeLuca. Brain 2020
10
50

Differing trends in the incidence of vascular comorbidity in MS and the general population.
Ruth Ann Marrie, John Fisk, Helen Tremlett, Christina Wolfson, Sharon Warren, James Blanchard, Scott B Patten. Neurol Clin Pract 2016
23
50

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.
E Kingwell, M Koch, B Leung, S Isserow, J Geddes, P Rieckmann, H Tremlett. Neurology 2010
57
50

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
Anja Thormann, Melinda Magyari, Nils Koch-Henriksen, Bjarne Laursen, Per Soelberg Sørensen. J Neurol 2016
28
50


Hazard rate ratio and prospective epidemiological studies.
M J Symons, D T Moore. J Clin Epidemiol 2002
148
50

Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study.
Christian Fynbo Christiansen, Steffen Christensen, Dóra Körmendiné Farkas, Montserrat Miret, Henrik Toft Sørensen, Lars Pedersen. Neuroepidemiology 2010
91
50

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
208
50

Human skin fibroblast telomeres are shortened after ultraviolet irradiation.
H-M Ma, W Liu, P Zhang, X-Y Yuan. J Int Med Res 2012
15
50




Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Tomas Kalincik, Vino Vivek, Vilija Jokubaitis, Jeannette Lechner-Scott, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Francois Grand'maison, Raymond Hupperts, Celia Oreja-Guevara,[...]. Brain 2013
90
50

Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Gongbu Pan, Steve Simpson, Ingrid van der Mei, Jac C Charlesworth, Robyn Lucas, Anne-Louise Ponsonby, Yuan Zhou, Feitong Wu, Bruce V Taylor. J Neurol Neurosurg Psychiatry 2016
25
50

Body size and physical exercise, and the risk of multiple sclerosis.
Marianna Cortese, Trond Riise, Kjetil Bjørnevik, Kjell-Morten Myhr. Mult Scler 2018
15
50

Telomere length and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies.
Lee Smith, Claudio Luchini, Jacopo Demurtas, Pinar Soysal, Brendon Stubbs, Mark Hamer, Alessia Nottegar, Rita T Lawlor, Guillermo Felipe Lopez-Sanchez, Joseph Firth,[...]. Ageing Res Rev 2019
23
50

The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study.
Jason Y Y Wong, Immaculata De Vivo, Xihong Lin, Shona C Fang, David C Christiani. PLoS One 2014
72
50

The serial cultivation of human diploid cell strains.
L HAYFLICK, P S MOORHEAD. Exp Cell Res 1961
50

Relation between sex hormones and leucocyte telomere length in men with idiopathic pulmonary fibrosis.
Chuling Fang, Hui Huang, Qian Zhang, Na Wang, Xiaoyan Jing, Jian Guo, Martin Ferianc, Zuojun Xu. Respirology 2020
3
50

Therapeutic Targeting of Telomerase.
Kathrin Jäger, Michael Walter. Genes (Basel) 2016
64
50


Telomeres in neurological disorders.
Ayyappan Anitha, Ismail Thanseem, Mahesh Mundalil Vasu, Vijitha Viswambharan, Suresh A Poovathinal. Adv Clin Chem 2019
14
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.